Literature DB >> 28797537

Mortality associated with less intense risk-factor control among adults with diabetes in the United States.

Sharon H Saydah1, Edward W Gregg2, Henry S Kahn2, Mohammed K Ali3.   

Abstract

AIMS: Determine the mortality experience among adults with diabetes in meeting and not meeting less intense control for glycated hemoglobin (HbA1c), blood pressure (BP), and cholesterol.
METHODS: National Health and Nutrition Examination Survey 1999-2010 participants with self-report of diagnosed diabetes (N=3335), measured HbA1c, BP and non-HDL cholesterol were linked to the National Death Index through December 31, 2011. Proportional hazards models were used to estimate hazard ratios (HR) of meeting HbA1c<9% and BP<160/110, and non-HDL cholesterol<190mg/dL. Models used age as the time scale and adjusted for demographics (sex, race/ethnicity, education), diabetes duration, history of cardiovascular and chronic kidney disease, and treatments for elevated glucose, BP, and cholesterol.
RESULTS: Over a mean 5.4 person-years of follow-up, participants meeting all less intense control had a 37% lower mortality (HR=0.63, 95% CI 0.54, 0.74) relative to those who did not meet the goals. Of approximately 306,000 deaths per year that occur among Americans with diabetes, we estimate 39,400 might have been averted by improving the care of those who have not met these less intense control goals.
CONCLUSIONS: Meeting the less intense control goals is associated with 37% reduction in mortality and could lead to 39,400 fewer deaths per year.
Copyright © 2017. Published by Elsevier Ltd.

Entities:  

Keywords:  A1c; Blood pressure; Cholesterol; Diabetes; Mortality; NHANES

Mesh:

Substances:

Year:  2017        PMID: 28797537     DOI: 10.1016/j.pcd.2017.07.004

Source DB:  PubMed          Journal:  Prim Care Diabetes        ISSN: 1878-0210            Impact factor:   2.459


  3 in total

1.  Leveraging Population-Based Clinical Quantitative Phenotyping for Drug Repositioning.

Authors:  Adam S Brown; Danielle Rasooly; Chirag J Patel
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2018-01-24

2.  Investigating the effect of transcendental meditation on spiritual wellbeing of Type-2 diabetic amputees: A clinical trial study.

Authors:  Ali Heydari Movahed; Fakhri Sabouhi; Reza Mohammadpourhodki; Sepideh Mahdavi; Sima Goudarzian; Malihe Amerian; Mona Mohtashami; Mansoure Kheiri; Malihe Imeni
Journal:  Heliyon       Date:  2020-11-30

3.  Cardiovascular disease prevalence and risk factor prevalence in Type 2 diabetes: a contemporary analysis.

Authors:  S McGurnaghan; L A K Blackbourn; E Mocevic; U Haagen Panton; R J McCrimmon; N Sattar; S Wild; H M Colhoun
Journal:  Diabet Med       Date:  2018-10-10       Impact factor: 4.359

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.